Tanvex BioPharma, Inc. announced the appointment of Chen, Lin-Cheng as CEO, effective February 6, 2024. Chen, Lin-Cheng is Chairman of the company and previously served as Acting CEO.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48 TWD | +1.05% | +4.12% | -26.27% |
1st Jan change | Capi. | |
---|---|---|
-26.27% | 241M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Announces the Appointment of Chen, Lin-Cheng as CEO